Study Shows Simeprevir Improves Hep C Therapy | Hepatitis Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search
Previous

Should Hepatitis C Treatment Include Selenium?

Back to News Homepage
Next

Priority Review Granted to Hep C Drug Simeprevir

Study Shows Simeprevir Improves Hep C Therapy

The Editors at Hepatitis Central
May 7, 2013

Print this page

Major improvements in Hepatitis C treatment response were seen when simeprevir was added to interferon-based therapy.

Addition of simeprevir to peginterferon/ribavirin improves SVR rate among HCV patients

May 1, 2013

Simeprevir improves rates of sustained virologic response and may allow for a 24-week treatment duration when added to interferon-based therapy for chronic hepatitis C, according to data presented at the International Liver Congress in Amsterdam.

Continue reading this entire article:
http://www.healio.com/hepatology/chronic-hepatitis/news/online/%7B0BDBD39D-184B-496C-AFA9-7338569379F3%7D/Addition-of-simeprevir-to-peginterferonribavirin-improves-SVR-rate-among-HCV-patients

1 Comment
Share
Share
Previous

Should Hepatitis C Treatment Include Selenium?

Back to News Homepage
Next

Priority Review Granted to Hep C Drug Simeprevir

Requirements for using and reposting articles

Comments

HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.